These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 1846816

  • 1. Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus.
    Gosselin J, Menezes J, D'Addario M, Hiscott J, Flamand L, Lamoureux G, Oth D.
    Eur J Immunol; 1991 Jan; 21(1):203-8. PubMed ID: 1846816
    [Abstract] [Full Text] [Related]

  • 2. Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinases.
    D'Addario M, Ahmad A, Morgan A, Menezes J.
    J Mol Biol; 2000 May 19; 298(5):765-78. PubMed ID: 10801347
    [Abstract] [Full Text] [Related]

  • 3. Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study.
    Gosselin J, Flamand L, D'Addario M, Hiscott J, Stefanescu I, Ablashi DV, Gallo RC, Menezes J.
    J Immunol; 1992 Jul 01; 149(1):181-7. PubMed ID: 1318897
    [Abstract] [Full Text] [Related]

  • 4. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha.
    Gosselin J, Flamand L, D'Addario M, Hiscott J, Menezes J.
    J Clin Invest; 1992 Jun 01; 89(6):1849-56. PubMed ID: 1318324
    [Abstract] [Full Text] [Related]

  • 5. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
    Hedrick JA, Watry D, Speiser C, O'Donnell P, Lambris JD, Tsoukas CD.
    Eur J Immunol; 1992 May 01; 22(5):1123-31. PubMed ID: 1315687
    [Abstract] [Full Text] [Related]

  • 6. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR, McNaughton ME, Cooper NR.
    J Immunol; 1985 Nov 01; 135(5):3068-73. PubMed ID: 2995485
    [Abstract] [Full Text] [Related]

  • 7. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
    Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ.
    J Clin Invest; 1997 Oct 15; 100(8):1969-79. PubMed ID: 9329960
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.
    Sinha SK, Todd SC, Hedrick JA, Speiser CL, Lambris JD, Tsoukas CD.
    J Immunol; 1993 Jun 15; 150(12):5311-20. PubMed ID: 8390533
    [Abstract] [Full Text] [Related]

  • 9. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
    Finnegan A, Roebuck KA, Nakai BE, Gu DS, Rabbi MF, Song S, Landay AL.
    J Immunol; 1996 Jan 15; 156(2):841-51. PubMed ID: 8543841
    [Abstract] [Full Text] [Related]

  • 10. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB, Montalvo EA, McClain KL, Ench Y, Heard P, Christy BA, Dewalt-Hagan PJ, Moyer MP.
    J Med Virol; 1999 Jan 15; 57(1):36-46. PubMed ID: 9890420
    [Abstract] [Full Text] [Related]

  • 11. Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction.
    Masucci MG, Szigeti R, Ernberg I, Hu CP, Torsteinsdottir S, Frade R, Klein E.
    Eur J Immunol; 1987 Jun 15; 17(6):815-20. PubMed ID: 3036539
    [Abstract] [Full Text] [Related]

  • 12. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
    Jang CH, Choi JH, Byun MS, Jue DM.
    Rheumatology (Oxford); 2006 Jun 15; 45(6):703-10. PubMed ID: 16418198
    [Abstract] [Full Text] [Related]

  • 13. CD4 mRNA expression in CD19-positive B cells and its suppression by the Epstein-Barr virus.
    Zhang RD, Henderson EE.
    Virology; 1994 Feb 15; 198(2):709-13. PubMed ID: 7507284
    [Abstract] [Full Text] [Related]

  • 14. The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.
    Takimoto T, Umeda R, Glaser R.
    Acta Virol; 1989 Aug 15; 33(4):375-7. PubMed ID: 2574946
    [Abstract] [Full Text] [Related]

  • 15. Measles virus infection enhances IL-1 beta but reduces tumor necrosis factor-alpha expression in human monocytes.
    Leopardi R, Vainionpää R, Hurme M, Siljander P, Salmi AA.
    J Immunol; 1992 Oct 01; 149(7):2397-401. PubMed ID: 1527385
    [Abstract] [Full Text] [Related]

  • 16. Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection.
    Arnold R, König B, Galatti H, Werchau H, König W.
    Immunology; 1995 Jul 01; 85(3):364-72. PubMed ID: 7558123
    [Abstract] [Full Text] [Related]

  • 17. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J, Pai S, Cotter M, Robertson ES.
    Virology; 1999 Sep 15; 262(1):18-30. PubMed ID: 10489337
    [Abstract] [Full Text] [Related]

  • 18. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
    Carel JC, Frazier B, Ley TJ, Holers VM.
    J Immunol; 1989 Aug 01; 143(3):923-30. PubMed ID: 2473114
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.
    Goto M, Yamada K, Katayama K, Tanaka I.
    Mol Pharmacol; 1996 May 01; 49(5):860-73. PubMed ID: 8622636
    [Abstract] [Full Text] [Related]

  • 20. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL, Rowe M, Cope AP, Feldmann M, Brennan FM.
    Eur J Immunol; 1994 Aug 01; 24(8):1879-85. PubMed ID: 8056047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.